Sedation, orthostasis and priapism are each predicted from a receptor trazodone fills early in this MN660 Unit 3 profile analysis, which treats affinity rankings as forecasts. Searches like "mn 660 unit 3 assignment example", "mn660 unit 3 sample" and "mn660 unit 3 example" land here.
What a finished MN660 Unit 3 receptor profile analysis looks like
A ranked table opens the analysis. Its top rows are 5-HT2A antagonism and alpha-1 adrenergic antagonism, the two sites trazodone binds most tightly; H1 antagonism, 5-HT2C antagonism and serotonin transporter inhibition follow at lower affinity, with published values that overlap. Affinities appear as Ki ranges from the NIMH Psychoactive Drug Screening Program database, and a final column translates each into occupancy language: which sites fill at low exposure and which only at high. Four prediction paragraphs sit beneath the table. Sedation is attributed jointly to H1, 5-HT2A and alpha-1 blockade. Orthostatic hypotension follows from alpha-1 blockade in vascular smooth muscle, and priapism from the same receptor in erectile tissue. The comparatively low rate of sexual side effects is linked, cautiously, to 5-HT2A antagonism. A closing paragraph covers the metabolite mCPP.
How a MN660 Unit 3 example is structured
Placing the table at the top means every later paragraph can cite a specific row above it. A short methods note explains where the affinity values came from and warns that Ki figures from different assays can differ several-fold, so the analysis compares ranks rather than trusting single numbers. Each prediction paragraph then runs in one order: receptor, the tissue where it matters, what blockade does there, what the patient would report, and how confident the link is. Sedation comes first as the most common report, orthostasis second, priapism third as the rarest and most serious. The sexual function paragraph is deliberately hedged, since the 5-HT2A explanation is plausible rather than proven. The mCPP paragraph notes that CYP3A4 forms this metabolite, that it stimulates 5-HT2C rather than blocking it, and that CYP2D6 clears it. The product label and two reviews make up the reference list.
Ranks over raw numbers
Published Ki values for trazodone vary between laboratories, so the analysis compares which receptors fill first rather than quoting one figure as fact. That choice keeps the predictions stable whichever reference a reader goes on to check.
Why low and high exposure differ
The high-affinity sites, 5-HT2A and alpha-1, are occupied well before the serotonin transporter is. The analysis uses that gap to explain why the drug acts more like a sedative at low exposure, and it does so without quoting an amount.
One receptor, two warnings
Alpha-1 blockade appears twice: in arterioles as a fall in pressure on standing, and in the corpus cavernosum as priapism. Tying both warnings to one receptor is the analytical move this assignment usually rewards.
A hedge where one belongs
The lower rate of sexual dysfunction compared with SSRIs is credited to 5-HT2A antagonism with an explicit qualifier. The analysis presents the idea as a hypothesis and rests no other prediction on it.
A metabolite that reverses the sign
mCPP stimulates the very 5-HT2C receptor that trazodone blocks. Because CYP2D6 clears it, a strong 2D6 inhibitor could let it build up, a point that links this profile forward to the metabolism unit.
Where marks go in MN660 Unit 3
Where this assignment usually falls short is the table left as a table: accurate affinities, correctly sourced, followed by a side effect list copied from a drug guide and never connected to a row. Predictions that skip the tissue step lose credit too, since alpha-1 blockade means something different in an arteriole than in erectile tissue. Treating Ki figures as exact, or setting values from two different assays in one column as if they shared a scale, draws a methodological comment. Presenting the sexual function explanation as settled is marked as overreach. Graders also deduct for any sentence that recommends trazodone for sleep or names an amount, because the analysis concerns pharmacology rather than choice. Lesser losses follow from leaving out the metabolite and from calling trazodone an SSRI, which its profile plainly contradicts.
Get a MN660 Unit 3 example written to your instructions
Name the drug whose binding profile the Unit 3 prompt assigns, or let us pick a well-characterized one, and attach the rubric with any required table layout. Written to those instructions, your first analysis comes free within 24-48h: affinities ranked from a cited source, each converted into a predicted effect, and every uncertain link hedged in the text itself.
MN660 Unit 3 questions, answered
Where should affinity values come from?
A named database or a peer-reviewed review, cited in the table. The NIMH Psychoactive Drug Screening Program database is widely used and free to search, and product labels sometimes report binding data as well. Whatever the source, compare ranks rather than treating one Ki as exact, and avoid mixing values from different studies in a single column without saying so.
Should the analysis include every receptor the drug touches?
Only those the drug occupies meaningfully at clinical exposure, plus any weak ones that explain something important. For trazodone that means leaving out targets with negligible affinity. A profile padded with receptors that never fill at usual concentrations dilutes the predictions, and graders notice when a row adds nothing to the argument.
Can the analysis compare the drug with another agent?
Briefly, where the comparison sharpens a prediction. Setting trazodone's sexual side effect rate beside an SSRI's, for example, helps explain why 5-HT2A antagonism is proposed as protective. A couple of sentences is plenty unless the prompt requests more, since a full comparison between classes is a separate assignment that usually arrives later in the course.